News

Nestmedic, an innovative telemedicine company listed on NewConnect and the creator of Pregnabit mobile CTG, has signed an investment agreement with Agnieszka Kierner. A current member of the Supervisory Board is going to support the Company in its expansion to foreign markets. Agnieszka Kierner will take up 330,000 shares in the Company at the price of 1.50 PLN per share.

With the new investor and the capital injection of nearly half a million zloty, Nestmedic will be able to commercialise its flagship product – a mobile CTG device, known as Pregnabit, which is used to monitor fetal and maternal well-being at any time and anywhere, without having to visit a hospital or a clinic.

Agnieszka Kierner has been a corporate manager for 20 years. For many years, she worked as a HR director in one of the Polish start-ups which, following an impressive growth and success, was sold to tech giant, Atos. Her work was repeatedly acknowledged by various influential circles in the world of business. She has lived in the United States for many years now, currently in Boston – a centre of development of the medical, biomedical, pharmaceutical, and telemedical industries. She has long standing experience in investing in technological and telemedical businesses. A graduate of Executive MBA studies, a lecturer in management, strategic management and international human resource management at several international universities.

– Acquiring a new shareholder is a breakthrough for Nestmedic. We hope that new financial resources combined with experience and personal commitment of our new investor will make it possible for us to sign further commercial agreements on foreign markets. Starting from 2019, Pregnabit devices have also been available to patients in Finland and Bulgaria, comments Jacek Gnich, Nestmedic CEO.

Another Polish hospital has just started business cooperation with Nestmedic S.A. 10 telemedical Pregnabit devices for mobile CTG are now at the disposal of the Independent Public Health Care Centre in Głubczyce. Remote CTG testing will expand the Centre’s offer of perinatal care services. The labour ward of the hospital in Głubczyce was in the top ten of the “Childbirth with Dignity” ranking. This is the Company’s third contract with a Polish healthcare facility since the beginning of December.

With the Pregnabit telemedical system in place, pregnant patients of the hospital in Głubczyce will be able to perform the CTG examination at any time and anywhere, without having to visit the facility. 10 devices will expand the equipment base of one of the most renowned maternity wards in the Opolskie Voivodeship.

– We are systematically expanding the availability of Pregnabit mobile CTG in Polish healthcare facilities, including in hospitals from outlying locations. The hospital in Głubczyce is another public hospital that has decided to purchase our telemedical solution, thus expanding its service proposal for pregnant women, says Jacek Gnich, Nestmedic CEO.

The popularity of the Pregnabit system is constantly increasing. In 2019, the system was used for 3093 examinations all over Poland.

Recently, the company has established cooperation with major hospitals in Warsaw, Biała Podlaska and Białystok. At the same time, a pilot implementation programme is underway at Diagnostyka’s blood collection facilities: Pregnabit – a mobile CTG device is currently available at selected establishments of the network in Kraków. In addition, starting from 2019, Pregnabit telemedical CTG devices have also been available to patients in Finland and Bulgaria.

Remote pregnancy surveillance is safe, effective and may be implemented into everyday obstetric care – it is the main conclusion drawn from the studies carried out by scientists from Wrocław Medical University. The CTG examinations performed using mobile devices present satisfactory feasibility and equivalent diagnostic value compared to conventional devices, while the remote evaluation of recordings is as reliable as on-site analysis

more information